SCHEMBL6449490

SCHEMBL6449490

CCCC(CC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(CCC)CC(=O)N(C)Cc1ccccn1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.66
▸ TSHR P16473 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ REN P00797 4/20 0.44
▸ HDAC3 O15379 2/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC2 Q92769 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ KMT2A Q03164 1/20 0.40
▸ CTSD P07339 1/20 0.38
▸ MMP2 P08253 5/20 0.38
▸ MMP1 P03956 2/20 0.38
▸ MMP3 P08254 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449485 1.00 CA2 (0.66) CA2TSHRCYP1A2CYP2D6MAPT
SCHEMBL6449495 1.00 CA2 (0.66) CA2TSHRCYP1A2CYP2D6MAPT
SCHEMBL6446506 0.80 PTPRA (0.43) CA2MAPTSMN1; SMN2ALDH1A1KMT2A
A-76928 SCHEMBL6449595 0.79 CA2 (1.00) CA2TSHRCYP1A2CYP2D6MAPT
A-77003 SCHEMBL8749867 0.79 CA2 (1.00) CA2TSHRCYP1A2CYP2D6MAPT
A-77003 SCHEMBL7337518 0.79 CA2 (1.00) CA2TSHRCYP1A2CYP2D6MAPT
A-77003 SCHEMBL6448973 0.79 CA2 (1.00) CA2TSHRCYP1A2CYP2D6MAPT
A-77003 SCHEMBL2770013 0.79 CA2 (1.00) CA2TSHRCYP1A2CYP2D6MAPT
SCHEMBL7341313 0.78 CA2 (0.85) CA2TSHRCYP1A2CYP2D6MAPT
SCHEMBL7340523 0.78 CA2 (0.85) CA2TSHRCYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 — — EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 — — US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 — — EP disclosed
Send feedback